Cash & equivalents increased 101.2%
Cash & equivalents changed +101.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +101.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -1318 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -54.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -41.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed -5159 basis points from the comparable as-filed period.
Revenue changed -58.5% from the comparable as-filed period.
Research & development changed +30.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +10009 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed +37.6% from the comparable as-filed period.
Current assets changed +35.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +46.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed +30.3% from the comparable as-filed period.
Gross profit changed -69.4% from the comparable as-filed period.
R&D / revenue changed +495 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -2387 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -2329 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed +714 basis points from the comparable as-filed period.
Operating income changed -167.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed +84.3% from the comparable as-filed period.
Capital expenditure changed -40.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +44.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed +18684 basis points from the comparable as-filed period.
Working capital / assets changed +844 basis points from the comparable as-filed period.
Shares outstanding changed +14.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Inventory changed -10.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +58 basis points from the comparable as-filed period.
Selling, general & administrative changed -10.5% from the comparable as-filed period.
Current liabilities changed -6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed +847 basis points from the comparable as-filed period.
Cash & equivalents changed +92.5% from the comparable as-filed period.
Free-cash-flow proxy changed -136.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -250 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -133.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Current assets changed +47.4% from the comparable as-filed period.
Working capital changed +65.8% from the comparable as-filed period.
Trade receivables changed +112.3% from the comparable as-filed period.
Total assets changed +40.1% from the comparable as-filed period.
Capital expenditure changed -79.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -5668 basis points from the comparable as-filed period.
Revenue changed +22.4% from the comparable as-filed period.
Operating cash-flow margin changed -6540 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -6289 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +90.4% from the comparable as-filed period.
Working capital / assets changed +1153 basis points from the comparable as-filed period.
Current ratio changed +46.7% from the comparable as-filed period.
Receivables / revenue changed +7231 basis points from the comparable as-filed period.
Operating income changed +102.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory changed -18.4% from the comparable as-filed period.
Shares outstanding changed +14.0% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Gross profit changed +23.0% from the comparable as-filed period.
SBC / revenue changed +191 basis points from the comparable as-filed period.
Research & development changed -18.4% from the comparable as-filed period.
Gross margin changed +21 basis points from the comparable as-filed period.
R&D / revenue changed -160 basis points from the comparable as-filed period.
Current liabilities changed +0.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +4.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.